US Stock MarketDetailed Quotes
LADX LadRx
- 1.967500
- +0.467500+31.17%
15min DelayClose Dec 13 16:00 ET
974.09KMarket Cap-0.34P/E (TTM)
1.990000High1.640000Low4.67KVolume1.890000Open1.500000Pre Close8.91KTurnover0.95%Turnover Ratio2.89P/E (Static)495.09KShares3.50000052wk High-0.56P/B962.41KFloat Cap0.46210052wk Low--Dividend TTM489.16KShs Float162225.000000Historical High--Div YieldTTM23.33%Amplitude0.462100Historical Low1.909000Avg Price1Lot Size
About LadRx Company
LadRx Corp. is a biopharmaceutical research and development company. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel technologies targeting chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The company was founded in 1985 and is headquartered in Los Angeles, CA.
Company Profile
SymbolLADX
Company NameLadRx
Founded1985
MarketPink Market
Employees2
Fiscal Year Ends12-31
Address11726 San Vicente Boulevard,Suite 650
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90049
Phone1-310-826-5648
Websitehttp://www.ladrxcorp.com
Company Executives
- Name
- Position
- Salary
- Stephen Snowdy
- Chief Executive Officer
- --
- John Y. Caloz
- Corporate Secretary, Chief Financial Officer, Chief Accounting Officer, Treasurer and Senior Vice President
- --
- Dr. Jennifer K. Simpson
- Independent Chairman of the Board
- --
- Joel Caldwell
- Lead Independent Director
- --
- Cary Claiborne
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
